A matrixed approach to long-term stability testing of pharmaceutical products is presented. The basic matrix design, suitable for testing three lots at one storage condition, may be extended to multiple product presentations or storage conditions. The design has full testing at the endpoints (0 and 36 months) and partial testing at the interim time points (3, 6, 9, 12, 18, and 24 months). The test points were selected with the assistance of a statistical search algorithm. The proposed matrix design provides a 37.5% reduction in analytical testing, while still permitting a reliable interim expiry estimate based on 12-month stability data. The expiration dating periods estimated using the matrixed approach are typically more conservative than estimates derived from a full-testing approach. A comparison of expiration dating period estimates for a metered-dose inhaler and capsule drug product using the matrixed and full-testing approaches is presented.

Download full-text PDF

Source
http://dx.doi.org/10.1021/js950034iDOI Listing

Publication Analysis

Top Keywords

matrixed approach
12
approach long-term
8
long-term stability
8
stability testing
8
testing pharmaceutical
8
pharmaceutical products
8
matrix design
8
expiration dating
8
testing
6
matrixed
4

Similar Publications

Article Synopsis
  • The multisensor concept provides a fast and reliable way to assess gases and odors by mimicking biological detection systems through pattern recognition.
  • The study details the development of a sensor array using metal oxide nanostructures, specifically growing various oxides (Co, Ni, Mn, and Zn) on a chip to create chemiresistive films.
  • Results indicate that these nanostructures, particularly ZnO, enhance the sensor's performance, allowing detection of alcohol vapors at very low concentrations due to their high-sensitivity signals.
View Article and Find Full Text PDF
Article Synopsis
  • Innovation is sought after in healthcare but its programs’ effectiveness is often unmeasured, especially regarding employee experiences, which led to the creation of the VA innovators network (iNET) to enhance patient care and processes.
  • A study involving interviews with 50 participants across 15 sites revealed that many felt revitalized and appreciated new connections and recognition, though some faced challenges like time constraints.
  • The findings indicate that iNET effectively promotes innovation and positively influences employee experiences, suggesting that similar programs could help address issues like burnout in the post-pandemic healthcare landscape.
View Article and Find Full Text PDF

Characterization of lncRNA and mRNA profiles in the process of repairing peripheral nerve defects with cell-matrixed nerve grafts.

BMC Genomics

September 2024

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Co-Innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, 226001, Jiangsu, China.

Background: Decellularized extracellular matrix (dECM) is an intriguing natural biomaterial that has garnered significant attention due to its remarkable biological properties. In our study, we employed a cell-matrixed nerve graft for the repair of sciatic nerve defects in rats. The efficacy of this approach was assessed, and concurrently, the underlying molecular regulatory mechanisms were explored to elucidate how such grafts facilitate nerve regeneration.

View Article and Find Full Text PDF

Factors associated with successful FLOW implementation to improve mental health access: a mixed-methods study.

Transl Behav Med

November 2024

Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA.

Article Synopsis
  • - The FLOW program helps mental health providers move patients who have stabilized in specialty mental health care to primary care, aiming to improve access to such services across nine VA sites, where implementation was varied.
  • - The study uses the Consolidated Framework for Implementation Research (CFIR) to identify factors that contribute to successful implementation, utilizing a mixed-methods approach to analyze different metrics across the sites.
  • - Key themes for successful implementation include positive perceptions of the FLOW intervention, a supportive recovery-oriented care culture, low turnover of mental health providers, and effective internal facilitators, while other aspects like staffing and leadership support showed inconsistent effects.
View Article and Find Full Text PDF

Advances in microbiome therapeutics have been motivated by a deeper understanding of the role that the gastrointestinal microbiome plays in human health and disease. The FDA approval of two stool-derived live biotherapeutic products (LBPs), REBYOTA® 150 mL enema (fecal microbiota, live-jslm; formerly RBX2660) and VOWST® oral capsules (fecal microbiota spores, live-brpk; formerly SER-109), for the prevention of recurrent CDI in adults following antibiotic treatment for recurrent CDI provides promise and insights for the development of LBPs for other diseases associated with microbiome dysfunction. Donor-derived products carry risk of disease transmission that must be mitigated through a robust donor screening program and downstream manufacturing controls.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!